Feedback

Dr. Hemant R. Jadhav

Professor, Department of Pharmacy,
BITS Pilani, Pilani Campus

Pharmaceutical Chemistry
Department of Pharmacy, Birla Institute of Technology & Science, Pilani- 333031, Rajasthan. India.

Sponsored Projects

Sr. No.

Title of the project

Role

Sanction No.

Funding Agency

Duration

Funds sanctioned (Rs., Lakh)

1

Design and Synthesis of Novel Agents for the Management of Rheumatoid Arthritis

PI

37-117/2009 (SR)

University Grants Commission

1/4/2010-31/3/2013

8.35

2

Design and Synthesis of Novel Agents for the Treatment of Rheumatoid Arthritis

PI

SR/FT/CS-100/2009

Department of Science and Technology

1/9/2010-31/8/2013

19.03

3

Analysis of herbal extracts and formulations for antioxidant activity

PI

 

Vedic Life Sciences, Mumbai, India

2006-07

0.5

4

Verifying the structural evidence for the presence of Sennosides

PI

 

Shashi Phytochemicals Limited, India

2012

0.5

5

Design, synthesis, and biological evaluations of b- secretase inhibitors as anti-Alzheimer's agents

Co-PI

DST/INT/Pol/P-21/2016

DST Indo-Polish Joint Research Programme. Project No.

DST/INT/Pol/P-21/2016. Indian PI: Dr. Ruchi Malik, Central Univ of Rajasthan and Polish PI: Prof. Slawomir Filipek, University of Warsaw, Warsaw, Poland

7/6/2017-6/6/2020

19.84

6

DBT-BUILDER -University of Birla Institute of Technology and Science Pilani, Pilani Campus: Interdisciplinary Life Science Programme for Advanced Research and Education in Epigenetics and Genome Editing

Co-PI

BT/INF/22/SP42545/2021

Department of Biotechnology

24/9/2021-23/9/2026

901.8

7

Design, synthesis, and evaluation of novel dual inhibitors of Angiotensin-II type 1 receptor and Neprilysin for the treatment of diabetic cardiomyopathy

PI

CRG/2022/004698

Science and Engineering Research Board

07/11/2023- 06/11/2026

33.02

8

Design, synthesis, and evaluation of novel dual inhibitors of dipeptidyl peptidase 4 (DPPIV) and Neprilysin for the treatment of diabetes           

PI

IIRP-2023-6880

ICMR

Sanctioned

30.06